Benaissa Elmostafa, Belouad Elmehdi, Mechal Youness, Benlahlou Yassine, Chadli Mariama, Maleb Adil, Elouennass Mostafa
PhD, Department of Clinical Bacteriology, Mohammed V Military Teaching Hospital, Research Team of Epidemiology and Bacterial Resistance, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, avenue Mohamed Belarbi El Alaoui, B.P. 6203, Rabat, Morocco.
Msc, Department of Clinical Bacteriology, Mohammed V Military Teaching Hospital, Research Team of Epidemiology and Bacterial Resistance, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, avenue Mohamed Belarbi El Alaoui, B.P. 6203, Rabat, Morocco.
Germs. 2021 Dec 29;11(4):562-569. doi: 10.18683/germs.2021.1291. eCollection 2021 Dec.
Urinary tract infection is very common and is the second most frequent reason for consultation in office-based practice. The incidence varies from one country to another. The diffusion of MDR in the community complicates therapeutic management. The objective of this study was to describe the bacterial epidemiology and to determine the risk factors for the acquisition of MDR in community urinary tract infections in our region.
This was a retrospective case-control study conducted in the bacteriology laboratory of the Mohammed V Military Teaching Hospital over an 8-month period from 01 October 2015 to 31 May 2016. Cases were defined as patients with community-acquired urinary tract infection with MDR and controls were defined as patients with a urinary tract infection without MDR.
Out of 373 isolates, enterobacteria represented 80%. represented 59.2%, followed by at 15%. The rate of MDR represented 13.4% of which ESBL enterobacteria represented 12.1%. Univariate analysis showed a statistically significant association between male sex (p=0.001), age >65 years (p=0.007), urban origin (p=0.003), previous hospitalization within 3 months (p=0.001) and antibiotic therapy within 6 months (p=0.001) with MDR community-acquired urinary tract infection. On the other hand, multivariate analysis by logistic regression showed that age >65 years (OR=8.4, CI: 2.1-42), previous hospitalization within 3 months (OR=13.4, CI: 3.3-140.2) and antibiotic therapy within 6 months (OR=9.2, CI: 4.1-60.1) were significantly associated to MDR community-acquired urinary tract infection.
The increase in resistance to enterobacteria in the community prompts a review of the list of antibiotics prescribed for probabilistic management of these infections in our region.
尿路感染非常常见,是门诊医疗中第二常见的就诊原因。发病率因国家而异。社区中多重耐药菌的传播使治疗管理变得复杂。本研究的目的是描述细菌流行病学,并确定我们地区社区获得性尿路感染中多重耐药菌感染的危险因素。
这是一项回顾性病例对照研究,于2015年10月1日至2016年5月31日在穆罕默德五世军事教学医院细菌学实验室进行,为期8个月。病例定义为社区获得性多重耐药性尿路感染患者,对照定义为无多重耐药性的尿路感染患者。
在373株分离菌中,肠杆菌占80%。其中[此处原文缺失具体细菌名称]占59.2%,其次是[此处原文缺失具体细菌名称]占15%。多重耐药率为13.4%,其中产超广谱β-内酰胺酶肠杆菌占12.1%。单因素分析显示,男性(p = 0.001)、年龄>65岁(p = 0.007)、城市来源(p = 0.003)、3个月内曾住院(p = 0.001)和6个月内接受过抗生素治疗(p = 0.001)与社区获得性多重耐药性尿路感染之间存在统计学显著关联。另一方面,逻辑回归多因素分析显示,年龄>65岁(OR = 8.4,CI:2.1 - 42)、3个月内曾住院(OR = 13.4,CI:3.3 - 140.2)和6个月内接受过抗生素治疗(OR = 9.2,CI:4.1 - 60.1)与社区获得性多重耐药性尿路感染显著相关。
社区中肠杆菌耐药性的增加促使我们重新审视本地区针对这些感染进行概率性管理所开具的抗生素清单。